Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Fins on sedar

<< Previous

Bullboard Posts

Next >>

Comment by lscfaon Feb 29, 2024 3:08pm

159 Views

Post# 35907308

RE:RE:RE:RE:RE:RE:Fins on sedar

Corrected my table to reflect no.s in note 12...

Qtr ending	Sales to Abbvie	R+F settlement	Other income	Total Revenue + Other income
Oct 23	22,970	0	8,846	31,816
Jul 23	6,815	0	16	6,831
Apr 23	4,994	54,520	1,388	60,902
Jan 23	0	0	1,467	1,467
Total	34,779	54,520	11,717	101,016